Lenka N.C. Boyd
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- Geert Kazemier (12 shared papers)Godefridus J. Peters (2 shared papers)Elisa Giovannetti (11 shared papers)Hanneke W.M. van Laarhoven (8 shared papers)Tessa Y. S. Le Large (9 shared papers)Laura L. Meijer (10 shared papers)Thang V. Pham (2 shared papers)Connie R. Jiménez (2 shared papers)
- Journals
- Clinical Cancer Research (1 paper)PLoS ONE (1 paper)Cancer Immunology Immunotherapy (1 paper)Cells (1 paper)Expert Review of Clinical Pharmacology (1 paper)
- Partner nations
- NetherlandsItalyUnited Kingdom
In The Last Decade
Lenka N.C. Boyd
15 papers receiving 246 citations
Peers
Comparison fields: 5 of 46
- Oncology 120
- Cancer Research 66
- Immunology 34
- Molecular Biology 95
- Biotechnology 7
Countries citing papers authored by Lenka N.C. Boyd
This map shows the geographic impact of Lenka N.C. Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lenka N.C. Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lenka N.C. Boyd more than expected).
Fields of papers citing papers by Lenka N.C. Boyd
This network shows the impact of papers produced by Lenka N.C. Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lenka N.C. Boyd. The network helps show where Lenka N.C. Boyd may publish in the future.
Co-authors
The 25 scholars most cited alongside Lenka N.C. Boyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 72 | |
| 2 | 2020 | 38 | |
| 3 | 2022 | 34 | |
| 4 | 2019 | 28 | |
| 5 | 2019 | 23 | |
| 6 | 2022 | 15 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2024 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 1 | |
| 15 | 2024 | 1 |
About Lenka N.C. Boyd
Lenka N.C. Boyd is a scholar working on Oncology, Cancer Research, Surgery, Molecular Biology and Immunology, having authored 15 papers that have together received 248 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer Genomics and Diagnostics (2 papers), Statistical Methods in Clinical Trials (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Oncology (120 citations), Cancer Research (66 citations), Immunology (34 citations), Molecular Biology (95 citations) and Biotechnology (7 citations). Lenka N.C. Boyd has collaborated with scholars based in Netherlands, Italy and United Kingdom. Frequent co-authors include Geert Kazemier, Godefridus J. Peters, Elisa Giovannetti, Hanneke W.M. van Laarhoven, Tessa Y. S. Le Large, Laura L. Meijer, Thang V. Pham, Connie R. Jiménez, Sander R. Piersma and Tim Schelfhorst. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Cancer Immunology Immunotherapy, Cells and Expert Review of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.